SZShuo-Ran Zhao

Shuo-Ran Zhao

*This is an algorithmically generated author record based on publicly available information.

Shuo-Ran Zhao has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Internal Jugular Vein Thrombosis After Microwave Ablation of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Case Report

    by Ying Liu, Xi-Ju Wang, Jin-Ling Wang, Li-Hong Liu, Shuo-Ran Zhao, Shou-Jun Yu, Bei-Bei Yang, Qing-Ling Xu, Jin-Ke Li, Shu-Rong Wang

    In this study, two patients with papillary thyroid carcinoma and lymph node metastasis were treated by Dr. Shurong Wang’s team and are reported. The two patients refused surgery and underwent microwave ablation (MWA) of the thyroid and lymph node lesions. Ultrasound review 2 days after MWA revealed internal jugular vein thrombosis. Patient #1 received low molecular weight heparin calcium injection, Xueshuantong injection, Xiangdan injection, and rivaroxaban. Patient #2 was treated with enoxaparin sodium injection, Xueshuantong injection, urokinase, and warfarin sodium tablet. The thrombus was successfully managed in each patient using anticoagulant treatment. Such complication of MWA has not been reported in many cases before. According to the relevant literature, thrombosis after thyroid cancer ablation might be related to subclinical hypothyroidism, increased heme oxidase 1 (HO-1) levels in the blood of patients with papillary thyroid cancer, and increased platelet content and mean platelet volume in patients with thyroid cancer. No specific cause of thrombosis was identified in the two cases reported here. No recurrence was observed after 1 (patient #1) and 4 (#2) years of follow-up. In conclusion, patients with papillary thyroid carcinoma and lymph node metastasis should undergo color Doppler ultrasound of the neck after MWA of thyroid lesions and neck metastasis.


  • Retracted
    Open Access

    The Clinical Effect of High-Flow Oxygen Therapy through the Nose on Patients with Acute Left Heart Failure and Hypoxemia

    by Xinlei Hao, Shuoran Zhao, Jiajia Cheng, Lihua Yang, Haiming Jiang, Fuzheng Qu

    Objective. To evaluate the clinical efficacy of nasal high-flow oxygen therapy in patients with acute left heart failure and hypoxemia. Methods. From July 2016 to November 2018, patients with acute left heart failure complicated with hypoxemia treated in the Department of Critical Medicine of Yantai Affiliated Hospital of Binzhou Medical University were retrospectively observed (a total of 140 cases met the inclusion criteria). They were randomly divided into two groups, with 70 cases in each group. Patients were given continuous ECG monitoring, improved blood gas analysis test, and recorded HR, RR, map, SaO2, pH, PaO2, PaCO2, and Lac, perfect examination and color Doppler echocardiography, and record NT-proBNP and EF before and 24 hours after treatment. The effective rates of the two groups before and after oxygen therapy were detected. Results. There were 67 patients with high-flow oxygen therapy group improvement, 95.7% improvement rate, and 55 patients with general oxygen therapy group improvement rate. The treatment improvement rate was 78.6%. A total of 67 patients were treated with high-flow oxygen therapy. After high-flow oxygen therapy, HR (t = 18.8, ), RR (t = 19.7, ), MAP (t = 12.1, ), PaCO2 (t = 9.53, ), Lac (t = 8.69, ), and NT-proBNP (t = 7.03, ) were significantly lower than before. SaO2 (t = −12.4, ), pH (t = −12.2, ), PaO2 (t = −17.7, ), and EF (t = −13.4, ) were significantly higher than before. A total of 55 patients were in the general oxygen therapy group. After administration of ordinary oxygen therapy, HR (t = 18.2, ), RR (t = 10.8, ), MAP (t = 13.1, ), PaCO2 (t = 15.8, ), Lac (t = 7.1, ), and NT-proBNP (t = 10, ) were significantly lower than before. SaO2 (t = −15.5, ), pH (t = −4.5, ), PaO2 (t = −20, <svg xmlns:xlink="http://www.w3.org/1999/xlink"...